MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
40.18
+1.71 (4.45%)
At close: May 12, 2025, 4:00 PM
39.31
-0.87 (-2.17%)
After-hours: May 12, 2025, 7:11 PM EDT
MLTX Market Cap
MLTX has a market cap or net worth of $2.54 billion as of May 12, 2025. Its market cap has decreased by -4.69% in one year.
Market Cap
2.54B
Enterprise Value
2.10B
1-Year Change
-4.69%
Ranking
Category
Stock Price
$40.18
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $2.54B, an increase of 70,568.26%. That is a compound annual growth rate of 660.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 2.43B | -28.71% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |